Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Suk Ryu

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Breast Cancer Research and Treatment|October 7, 2015
Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancersHyeong-Gon Moon, Keunhee Oh, Jiwoo Lee, et al.
BMC Cancer|July 23, 2016
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analysesYaewon Yang, Seock-Ah Im, Bhumsuk Keam, et al.
Cell Reports|May 14, 2020
Protein Kinase A Catalytic Subunit Is a Molecular Switch that Promotes the Pro-tumoral Function of MacrophagesYi Rang Na, Jung Won Kwon, Da Young Kim, et al.
Journal of Breast Cancer|May 13, 2020
Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer PatientsYaewon Yang, Ahrum Min, Kyung-Hun Lee, et al.
Cancer Research and Treatment|August 20, 2021
A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast CancerJung Sun Kim, Koung Jin Suh, Dae-Won Lee, et al.
Breast Cancer Research and Treatment|January 24, 2019
Prognostic effects of abnormal DNA damage response protein expression in breast cancerKoung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
Breast Cancer Research : BCR|July 22, 2025
MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancerCheng Hyun Lee, Soo Young Park, Jae Seok Lee, et al.
Molecular Oncology|March 12, 2022
Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agentMinsun Jung, Kyung-Min Lee, Yebin Im, et al.
The Korean Journal of Internal Medicine|September 18, 2014
A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomeraseSu Jong Yu, Jae-Kyung Won, Han Suk Ryu, et al.
British Journal of Cancer|April 27, 2016
Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancerAn Na Seo, Hee Jin Lee, Eun Joo Kim, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Breast Cancer Research and Treatment|October 7, 2015
Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancersHyeong-Gon Moon, Keunhee Oh, Jiwoo Lee, et al.
BMC Cancer|July 23, 2016
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analysesYaewon Yang, Seock-Ah Im, Bhumsuk Keam, et al.
Cell Reports|May 14, 2020
Protein Kinase A Catalytic Subunit Is a Molecular Switch that Promotes the Pro-tumoral Function of MacrophagesYi Rang Na, Jung Won Kwon, Da Young Kim, et al.
Journal of Breast Cancer|May 13, 2020
Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer PatientsYaewon Yang, Ahrum Min, Kyung-Hun Lee, et al.
Cancer Research and Treatment|August 20, 2021
A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast CancerJung Sun Kim, Koung Jin Suh, Dae-Won Lee, et al.
Breast Cancer Research and Treatment|January 24, 2019
Prognostic effects of abnormal DNA damage response protein expression in breast cancerKoung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
Breast Cancer Research : BCR|July 22, 2025
MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancerCheng Hyun Lee, Soo Young Park, Jae Seok Lee, et al.
Molecular Oncology|March 12, 2022
Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agentMinsun Jung, Kyung-Min Lee, Yebin Im, et al.
The Korean Journal of Internal Medicine|September 18, 2014
A novel prognostic factor for hepatocellular carcinoma: protein disulfide isomeraseSu Jong Yu, Jae-Kyung Won, Han Suk Ryu, et al.
British Journal of Cancer|April 27, 2016
Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancerAn Na Seo, Hee Jin Lee, Eun Joo Kim, et al.
Pageof 15